TherapeuticsMD Announces Third Quarter 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- S&P 500, Dow rise as AI boost counters US-Iran tensions
- Oil rises, as US-Iran strikes risk limiting already impaired supplies
- Dell again lifts annual forecasts as AI demand powers record results
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
TherapeuticsMD (TXMD) Misses Q3 EPS by 9c
November 12, 2024 4:16 PM ESTTherapeuticsMD (NASDAQ: TXMD) reported Q3 EPS of ($0.05), $0.09 worse than the analyst estimate of $0.04.
For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.
... More